Jump to content

Drilldown: Medicines

Choose a table:


Medicines > generic : 1P-LSD or 2C-B or Methylprednisolone

Use the filters below to narrow your results.

generic: (Click arrow to add another value)
brand:
None (1) · Medrol (oral), Solu-Medrol (IV/IM), Depo-Medrol (depot injection) (1) · Nexus, Eroxan (historical, late-1980s through mid-1990s) (1)
classes:
2C-x series (1) · Classic Psychedelic (1) · Lysergamide (1) · Phenethylamine (1) · Psychedelic (1) · Research material (1) · [[:Category:Corticosteroids|Corticosteroid]] (1) · [[:Category:Glucocorticoids|Glucocorticoid (intermediate-acting)]] (1) · [[:Category:Immunosuppressants|Immunosuppressant]] (1)
mechanism:
5-HT2A partial agonist (1) · Prodrug of LSD; 5-HT2A agonist (1) · '"`UNIQ--vote-00000860-QINU`"' Activates the glucocorticoid receptor to broadly remodel inflammatory, immune, and metabolic transcription. Unlike prednisone, it does not require hepatic activation, making it the preferred oral choice in severe hepatic dysfunction'"`UNIQ--ref-00000861-QINU`"'. (1)
uses:
None (2) · '"`UNIQ--vote-00000862-QINU`"', '"`UNIQ--vote-00000863-QINU`"', '"`UNIQ--vote-00000864-QINU`"', '"`UNIQ--vote-00000865-QINU`"', '"`UNIQ--vote-00000866-QINU`"' (1)
starting dose:
None (2) · PO Medrol Dosepak (5-day taper from 24 mg to 4 mg) is the prototypic short-course outpatient regimen; IV pulse 1 g daily for 3-5 days for MS relapse; intra-articular 4-80 mg per joint q1-5 weeks (1)
preparations:
None (2) · 2, 4, 8, 16, 32 mg oral tablets; 40, 125, 500, 1000 mg IV vials; Depo-Medrol 20, 40, 80 mg/mL IM depot (1)
fda max:
None (2) · Indication-specific (1)
routes:
None (1) · IM (1) · insufflated (1) · intra-articular (1) · intrathecal (rare and controversial) (1) · IV (1) · Oral (2) · PR (1)
onset:
None (1) · 45-75 min (oral) (1) · IV pulse: hours; PO: hours; intra-articular: days (1)
duration:
None (1) · 4-8 h (1) · Biologic 12-36 hours (intermediate-acting); Depo-Medrol depot weeks (1)
halflife:
None (1) · Not well characterized (1) · Plasma 2-3 hours; biologic ~18-36 hours'"`UNIQ--ref-00000867-QINU`"' (1)
bioavailability:
None (1) · Not well characterized (1) · ~80-99% (oral)'"`UNIQ--ref-00000868-QINU`"' (1)
pregnancy:
None (1) · Not established (1) · Use when benefits outweigh; small association with oral clefts in first trimester debated.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup> (1)
legal:
None (1) · [[USLegal:DEA Schedule I|Schedule I]] (United States) (1) · [[USLegal:Prescription only|Rx-only]] in US (1)

Showing below up to 3 results in range #1 to #3.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

1

2


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"